Transferrin and the transferrin receptor for the targeted delivery of therapeutic agents to the brain and cancer cells

Who is going to take this and use it to deliver therapeutic drugs to the penumbra to stop the neuronal cascade of death? Damn it, I expect answers, not dead silence from the WSO and stroke associations. Dr. Sacco, Mr. Baranski. What will it take to get the board of directors to install someone with a vision?
http://www.future-science.com/doi/abs/10.4155/tde.13.21

The potential use of many promising novel drugs is limited by their inability to specifically reach their site of action after intravenous administration, without secondary effects on healthy tissues. In order to remediate this problem, the protein transferrin (Tf) has been extensively studied as a targeting molecule for the transport of drug and gene delivery systems to the brain and cancer cells. A wide range of delivery approaches have been developed to target the Tf receptor and they have already improved the specific delivery of Tf-bearing therapeutic agents to their site of action. This review provides a summary of the numerous delivery strategies used to target the Tf receptor and focuses on recent therapeutic advances.

Full Text

PDF (1501 KB)

PDF Plus (1502 KB)